Literature DB >> 7549123

[Treatment of ifosfamide induced encephalopathy with methylene-blue].

J M Ferrero, P Eftekari, R Largillier, G Dreyfus, M Namer.   

Abstract

The authors report a case of encephalopathy after treatment with ifosfamide treated by a methylene blue infusion. This side-effect is rare but influenced by high doses and short infusions of this drug. Recently, a treatment of ifosfamide encephalopathy with methylene blue has been reported. This case report confirms the interest of such a treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549123

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Authors:  Karen I Sweiss; Rakesh Beri; Stacy S Shord
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Authors:  J Pelgrims; F De Vos; J Van den Brande; D Schrijvers; A Prové; J B Vermorken
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

3.  Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.

Authors:  Cindy Banh; Kendall Valsvik; Alejandra Arredondo; Kassie Notbohm; Emad Elquza; Hani Babiker; Andrew Kraft; Alejandro Recio Boiles; Daniel Persky; Alicia Ortega; Ali McBride
Journal:  Support Care Cancer       Date:  2021-11-26       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.